MENU
ONCT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Oncternal Therapeutics (ONCT) Ownership - Who owns Oncternal Therapeutics?
Profile
Industry
N/A
Address
12230 El Camino Real
Phone
+1 858 434-1113
Employees
30
Web
https://www.oncternal.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.56M
P/E Ratio
N/A
Total Cash
14.58M
Projected Growth
N/A
Total Debt
191K
Revenue
N/A
Risk (Beta)
1.10
Dividend Yield
N/A
Total Cash/Share
4.93
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
ONCT
Capitalization
1.56M
P/E Ratio
N/A
Risk (Beta)
1.10
Dividend Yield
N/A
Total Cash
14.6M
Total Cash/Share
4.93
Total Debt
191K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
9.15M
P/B Ratio
0.17
Cash Flow
N/A
Earnings
-11.69
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
3K
Current Ratio
2.39
Current Revenue Per Employee
18211.11
Dividends Per Share - Security
N/A
EBITDA
-35.96M
Float
N/A
Float - Current
N/A
Gross Income Margin
85.05
Revenue To Assets
-117.61
Shares Held By Institutions
2.5M
Shares Outstanding - Current
2.96M
Total Liabilities
6.45M
Total Volume MTD
N/A
Value
1
Gain YTD
-95.090
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a clinical-stage oncology company developing a diverse pipeline of treatments for cancers with critical unmet medical need.
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
12230 El Camino Real
Phone
+1 858 434-1113
Employees
30
Web
https://www.oncternal.com